Bloomlife provides a connected care platform for remote monitoring of high-risk pregnancies, utilizing cellular-enabled devices for automated vital sign capture and digital surveys for symptom tracking. This solution offers clinicians real-time data to proactively manage complications and improve maternal-fetal health outcomes.
Funding
$12.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
High-risk pregnancies often necessitate frequent in-clinic appointments and manual data collection for vital signs and symptoms, leading to patient burden and potential gaps in clinical oversight. This traditional approach can result in delayed interventions for conditions like hypertension and gestational diabetes, impacting maternal-fetal health outcomes.
Solution
Bloomlife offers a connected care platform designed for remote monitoring of high-risk pregnancies, enhancing patient compliance and clinical management. The platform utilizes cellular-enabled, FDA-cleared devices for automated data capture of blood pressure and glucose levels, alongside digital surveys for symptom tracking and mental health screening. This integrated approach provides clinicians with real-time, objective data to proactively identify and manage potential complications, improving care continuity and patient outcomes. The system aims to reduce administrative overhead for clinical teams, allowing them to dedicate more resources to direct patient care.
Target Audience
The primary customers are healthcare organizations, including health systems, private practices, and federally-qualified health clinics, that manage high-risk pregnancies and seek to improve patient outcomes and operational efficiency.
Features
- Cellular-enabled, FDA-cleared devices for automated blood pressure monitoring, proven to increase patient adherence.
- Support for continuous glucose monitoring and finger-stick glucose measurements with automated tracking and reminders.
- World's first patch-based home fetal monitoring solution (investigational device, FDA-cleared for maternal and fetal heart rate) for antenatal fetal surveillance.
- Clinically validated digital surveys for symptom collection, including PHQ-9 and EPDS, and customizable assessments for social determinants of health.
- Customizable clinical protocols and smart notifications to enhance clinical oversight and proactive intervention for high-risk patient populations.
- Enterprise-grade cybersecurity measures to ensure data integrity and patient privacy.
- Integration capabilities designed to align with existing clinical workflows for seamless adoption.
- Remote patient monitoring (RPM) capabilities that support new billable services for practices.